Synonymes : Phytic acid|83-86-3|Fytic acid|Phytate|Inositol hexaphosphate|Alkalovert|myo-inositol hexakisphosphate|myo-Inositol hexaphosphate|Alkovert|Phytine|Acide fytique|Acidum fyticum|Acido fitico|inositol hexakisphosphate|myo-Inositol, hexakis(dihydrogen phosphate)|Exfoderm|myo-Inosistol hexakisphosphate|(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate|CCRIS 4513|Phyliance|inositolhexaphosphoric acid|Dermofeel pa-3|Saure des phytins|Inositol hexaphosphoric acid|Saure des phytins [German]|Saeure des phytins|Acide fytique [INN-French]|Acido fitico [INN-Spanish]|Acidum fyticum [INN-Latin]|Phytin|Fytic acid [INN]|Inosithexaphosphorsaure|Inosithexaphosphorsaure [German]|1D-myo-inositol hexakisphosphate|Inositol 1,2,3,4,5,6-hexakisphosphate|CHEBI:17401|Inosithexaphosphorsaeure|EINECS 201-506-6|UNII-7IGF0S7R8I|NSC 269896|NSC-269896|7IGF0S7R8I|INOSITOL, HEXAKIS(DIHYDROGEN PHOSPHATE), myo-|myo-inositol hexakis(dihydrogen phosphate)|IP6|myo-Inositol, 1,2,3,4,5,6-hexakis(dihydrogen phosphate)|myo-Inositol 1,2,3,4,5,6-hexakisphosphate|D-chiro inositol hexakisphosphate|D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate|1D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate|NSC269896|Hexakis(dihydrogen phosphate) myo-inositol|Phyticacid|rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexayl hexakis(dihydrogen phosphate)|SNF-472|IHP|meso-Inositol hexaphosphate|Inositol hexakis(phosphate)|fytinsyre-|myo-Inositol hexakis(phosphate)|hexasodium-phytate|1zsh|(1R,2r,3S,4R,5s,6S)-cyclohexane-1,2,3,4,5,6-hexayl hexakis(dihydrogen phosphate)|C6H18O24P6|Phytic Acid Powder|1bq3|neo-Inositol hexaphosphate|Phytic acid (dry powder)|PHYTIC ACID [MI]|D0F3GG|D0KN1U|Epitope ID:144992|PHYTIC ACID [INCI]|scyllo-Inositol hexaphosphate|FYTIC ACID [MART.]|SCHEMBL19249|FYTIC ACID [WHO-DD]|D-chiro-Inositol hexaphosphate|SCHEMBL136587|GERD therapy (oral), Reviva|IP-6|myo-inositol hexaphosphoric acid|SCHEMBL1681470|SCHEMBL1681701|SCHEMBL1682030|SCHEMBL9164308|SCHEMBL9741350|SNF-03|SNF-04|CHEMBL1233511|CHEMBL2005481|SCHEMBL12137150|SCHEMBL12138455|SCHEMBL12549553|SCHEMBL15374707|SCHEMBL17006482|diphosphoinositol tetrakisphosphate|DTXSID00861653|DTXSID40889331|SNF-471|SNF-571|SNF-671|CHEBI:187038|HY-N0814|MFCD00082309|s3793|AKOS015856604|AKOS015901448|C6-H18-O24-P6|AC-8037|CCG-270338|CS-6330|DB14981|RP-3000|NCGC00483012-01|E391|LS-84062|NCI60_002200|NCI60_038627|Inositol Hexaphosporic Acid, Hexaphosphate|FT-0600486|FT-0689105|P0409|D-myo-Inositol-1,2,3,4,5,6-hexaphosphate|A14529|C01204|A840671|EN300-19650970|Q409679|SR-01000944523|Phytic Acid (ca. 50% in Water, ca. 1.1mol/L)|Q-201578|SR-01000944523-1|Gastroesophageal reflux disease therapy (oral), Reviva|SNF-571 (transdermal patch, renal calcium lithiasis), Sanifit|{[2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid|cyclohexane-1,2,3,4,5,6-hexayl hexakis[dihydrogen (phosphate)]|Phytate (tablet formulation, osteoporosis), Sanifit Laboratoris SL|SNF-471 (transdermal patch, cardiovascular calcification), Sanifit|Phosphoric acid mono-(2,3,4,5,6-pentakis-phosphonooxy-cyclohexyl) ester|{[(1r,2R,3S,4s,5R,6S)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid|InsP6 (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL|InsP6, (transdermal/patch formulation, renal calcium lithiasis), Sanifit Laboratoris SL|MYO-INOSITOL HEXAKISPHOSPHATE; INOSITOL 1,2,3,4,5,6-HEXAKISPHOSPHATE|Myo-inositol hexaphosphate (tablet formulation, osteoporosis), Sanifit Laboratoris SL|MYO-INOSITOL, 1,2,3,4,5,6-HEXAKIS(DIHYDROGEN PHOSPHATE),60% IN WATER|Phytate (intravenous formulation, cardiovascular calcifications), Sanifit Laboratoris SL|Phytate (transdermal/patch formulation, renal calcium lithiasis), Sanifit Laboratoris SL|rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaylhexakis(dihydrogenphosphate)|1,2,3,4,5,6-cyclohexanehexol, hexakis(dihydrogen phosphate), (1alpha,2alpha,3alpha,4beta,5alpha,6beta)-|Calcium metabolism modulator (subcutaneous/injectable formulation, cardiovascular calcifications), Sanifit Laboratoris SL|Calcium metabolism modulator (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL|Myo-inositol hexakisphosphate (transdermal patchformulation, cardiovascular calcifications), Sanifit Laboratoris SL|Myo-inositol hexaphosphate (intravenous formulation, cardiovascular calcifications), Sanifit Laboratoris SL|Myo-inositol hexaphosphate (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL|Myo-inositol hexaphosphate (transdermal/patch formulation, renal calcium lithiasis), Sanfit Laboratoris SL|Phytate (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL